Gofen & Glossberg’s Ionis Pharmaceuticals IONS Stock Holding History

Gofen & Glossberg’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,050	Closed	-$248K	–	451
2019 Q1	$248K	Buy	+3,050	New	+$197K	0.01%	377
2018 Q1	–	Sell	-5,060	Closed	-$255K	–	471
2017 Q4	$255K	Sell	5,060 -1,600	-24%	-$87.7K	0.01%	414
2017 Q3	$338K	Hold	6,660	–	–	0.01%	361
2017 Q2	$339K	Hold	6,660	–	–	0.01%	355
2017 Q1	$268K	Sell	6,660 -81	-1%	-$3.64K	0.01%	390
2016 Q4	$322K	Hold	6,741	–	–	0.01%	339
2016 Q3	$247K	Buy	+6,741	New	+$211K	0.01%	386
2016 Q2	–	Sell	-6,760	Closed	-$274K	–	459
2016 Q1	$274K	Buy	6,760 +100	+2%	+$4.06K	0.01%	367
2015 Q4	$412K	Hold	6,660	–	–	0.02%	296
2015 Q3	$269K	Hold	6,660	–	–	0.01%	361
2015 Q2	$383K	Sell	6,660 -130	-2%	-$8.27K	0.02%	310
2015 Q1	$432K	Sell	6,790 -6,250	-48%	-$424K	0.02%	299
2014 Q4	$805K	Hold	13,040	–	–	0.03%	231
2014 Q3	$506K	Hold	13,040	–	–	0.02%	268
2014 Q2	$449K	Sell	13,040 -850	-6%	-$26.8K	0.02%	276
2014 Q1	$708K	Hold	13,890	–	–	0.03%	225
2013 Q4	$553K	Hold	13,890	–	–	0.03%	248
2013 Q3	$521K	Sell	13,890 -7,990	-37%	-$239K	0.03%	242
2013 Q2	$588K	Buy	+21,880	New	+$465K	0.03%	218

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Gofen & Glossberg's IONS Position: Q2 2019 in Review

Gofen & Glossberg sold out of Ionis Pharmaceuticals (IONS) in Q2 2019, closing a stake of 3,050 shares — an estimated $248K sold.

Gofen & Glossberg first reported a position in IONS in Q2 2013 and held it in 19 quarters. The position peaked at $805K in Q4 2014. 396 funds tracked by Wall St. Rank hold IONS as of Q2 2019.

Gofen & Glossberg reported no remaining Ionis Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
Gofen & Glossberg sold 3,050 Ionis Pharmaceuticals shares in Q2 2019, an estimated $248K.
Gofen & Glossberg first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 19 quarters.
Gofen & Glossberg's Ionis Pharmaceuticals position peaked at $805K in Q4 2014.
396 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2019.

Based on Gofen & Glossberg's 13F filing for Q2 2019, filed 12 Jul 2019.